المؤلفون: Bas Hilberdink, Marlies Carbo, Davy Paap, Suzanne Arends, Thea Vliet Vlieland, Florus van der Giesen, Anneke Spoorenberg, Salima van Weely

المساهمون: Translational Immunology Groningen (TRIGR)

المصدر: Seminars in Arthritis and Rheumatism, 55. W B SAUNDERS CO-ELSEVIER INC
SEMINARS IN ARTHRITIS AND RHEUMATISM, 55. W B SAUNDERS CO-ELSEVIER INC

مصطلحات موضوعية: Ankylosing/drug therapy, Health Status, Physical activity recommendations, Supervised group exercise, Anesthesiology and Pain Medicine, Cross-Sectional Studies, Rheumatology, Spondylitis, Ankylosing/drug therapy, Spondylarthritis, Humans, Spondylitis, Ankylosing, Exercise, Axial Spondyloarthritis, Spondylarthritis/drug therapy, Spondylitis, Ankylosing spondylitis

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf3a1cdb456de6d44d8aca16ca587054
https://pubmed.ncbi.nlm.nih.gov/35661547

المؤلفون: Henning Locht, Melinda Magyari, Dorte Vendelbo Jensen, Finn Sellebjerg, Lene Dreyer, René Cordtz, Tine Iskov Kopp, Johan Askling, Bénédicte Delcoigne, Elizabeth V. Arkema

المصدر: Kopp, T I, Delcoigne, B, Arkema, E V, Magyari, M, Locht, H, Sellebjerg, F T, Cordtz, R L, Jensen, D V, Askling, J & Dreyer, L 2022, ' Response to: 'Neuroinflammatory events after anti-TNFα therapy' by Kaltsonoudis et al ', Annals of the Rheumatic Diseases, vol. 81, no. 5, e74, pp. E74 . https://doi.org/10.1136/annrheumdis-2020-217802

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Immunology, Arthritis, Psoriatic/drug therapy, Tumour necrosis factor alpha, Antirheumatic Agents/adverse effects, General Biochemistry, Genetics and Molecular Biology, Etanercept, 03 medical and health sciences, Neurological assessment, 0302 clinical medicine, Rheumatology, Etanercept/therapeutic use, Internal medicine, Epidemiology, Spondylitis, Ankylosing/drug therapy, Brain mri, medicine, Immunology and Allergy, Humans, Spondylitis, Ankylosing, 030203 arthritis & rheumatology, business.industry, Tumor Necrosis Factor-alpha, Arthritis, Psoriatic, 030104 developmental biology, Antirheumatic Agents, Tumor necrosis factor alpha, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7086c5d5631e5c304999a4eeee4d4e8
https://vbn.aau.dk/da/publications/c9ebf8dc-0f3a-4a18-9b19-40e91023d53a

المؤلفون: Vander Cruyssen, Bert, RIBBENS, Clio, Boonen, Annelies, Mielants, Herman, de Vlam, Kurt, Lenaerts, Jan, Steinfeld, Serge, Van den Bosch, Filip, Dewulf, Lode, Vastesaeger, Nathan

المصدر: Annals of the Rheumatic Diseases, 66 (8), 1072-7 (2007-08)

مصطلحات موضوعية: Antibodies, Monoclonal, Antirheumatic Agents, Immunoglobulin G, Receptors, Tumor Necrosis Factor, Tumor Necrosis Factor-alpha, Infliximab, Etanercept, Adult, Antibodies, Monoclonal/economics, Antibodies, Monoclonal/therapeutic use, Antirheumatic Agents/economics, Antirheumatic Agents/therapeutic use, Belgium/epidemiology, Cohort Studies, Drug Costs, Female, Guideline Adherence, Humans, Immunoglobulin G/economics, Immunoglobulin G/therapeutic use, Logistic Models, Male, Middle Aged, Receptors, Tumor Necrosis Factor/therapeutic use, Registries, Severity of Illness Index, Spondylitis, Ankylosing/drug therapy, Spondylitis, Ankylosing/epidemiology, Tumor Necrosis Factor-alpha/antagonists & inhibitors, Practice Patterns, Physicians', Rheumatology, Immunology and Allergy, Immunology, Biochemistry, Genetics and Molecular Biology (all), General Biochemistry, Genetics and Molecular Biology, Human health sciences, Sciences de la santé humaine, Rhumatologie

Relation: https://syndication.highwire.org/content/doi/10.1136/ard.2006.064543; urn:issn:0003-4967; urn:issn:1468-2060

URL الوصول: https://orbi.uliege.be/handle/2268/290106

المؤلفون: Frank Heldmann, Astrid van Tubergen, Jürgen Braun, Ivette Essers, Xenofon Baraliakos, Annelies Boonen, Casper Webers

المساهمون: Promovendi PHPC, Interne Geneeskunde, RS: CAPHRI - R3 - Functioning, Participating and Rehabilitation, MUMC+: MA Med Staf Artsass Interne Geneeskunde (9), MUMC+: MA Reumatologie (9)

المصدر: Arthritis Care and Research, 70(4), 608-616. Wiley
Arthritis Care & Research

مصطلحات موضوعية: Male, Health Knowledge, Attitudes, Practice, Ankylosing/drug therapy, Ankylosing Spondylitis, Cost-Benefit Analysis, DISEASE, 0302 clinical medicine, Interquartile range, NECROSIS-FACTOR, Spondylitis, Ankylosing/drug therapy, 030212 general & internal medicine, Biological Products/economics, INDEX, CURE, Practice, Infliximab/economics, Cost–benefit analysis, biology, Health Knowledge, Middle Aged, Europe, Patients/psychology, Cohort, Original Article, Female, Financing, medicine.drug, Adult, Financing, Personal, medicine.medical_specialty, Patients, BATH, Drug Costs, 03 medical and health sciences, Rheumatology, Willingness to pay, medicine, Journal Article, Humans, Spondylitis, Ankylosing, 030203 arthritis & rheumatology, CONTINGENT VALUATION, Biological Products, Contingent valuation, business.industry, Euros, Patient Acceptance of Health Care, biology.organism_classification, EFFICACY, Infliximab, Surgery, RHEUMATOID-ARTHRITIS, SHORT-TERM IMPROVEMENT, Financing, Personal/economics, Attitudes, HEALTH-CARE, Residence, Health Expenditures, business, Personal/economics, Spondylitis, Demography

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21055e5844582d3ad362d5a03a0b095f
https://cris.maastrichtuniversity.nl/en/publications/8df858cc-0d08-437c-86f5-96cbbb1995be

المؤلفون: Molnar, Christoph, Scherer, Almut, Baraliakos, Xenofon, de Hooge, Manouk, Micheroli, Raphael, Exer, Pascale, Kissling, Rudolf O, Tamborrini, Giorgio, Wildi, Lukas M, Nissen, Michael J, Zufferey, Pascal, Bernhard, Jürg, Weber, Ulrich, Landewé, Robert B M, van der Heijde, Désirée, Ciurea, Adrian, Rheumatologists of the Swiss Clinical Quality Management Program

المساهمون: University of Zurich, Ciurea, Adrian, Rheumatologists of the Swiss Clinical Quality Management Program, AII - Inflammatory diseases, Clinical Immunology and Rheumatology, AII - Amsterdam institute for Infection and Immunity

المصدر: Molnar, C, Scherer, A, Baraliakos, X, de Hooge, M, Micheroli, R, Exer, P, Kissling, R O, Tamborrini, G, Wildi, L M, Nissen, M J, Zufferey, P, Bernhard, J, Weber, U, Landewé, R B M, van der Heijde, D, Ciurea, A & Rheumatologists of the Swiss Clinical Quality Management Program 2018, ' TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity : results from the Swiss Clinical Quality Management cohort ', Annals of the Rheumatic Diseases, vol. 77, no. 1, pp. 63-69 . https://doi.org/10.1136/annrheumdis-2017-211544
Annals of the rheumatic diseases, vol. 77, no. 1, pp. 63-69
Annals of the Rheumatic Diseases, Vol. 77, No 1 (2018) pp. 63-69
Annals of the Rheumatic Diseases, 77(1), 63-69
Annals of the rheumatic diseases, 77(1), 63-69. BMJ Publishing Group

مصطلحات موضوعية: 0301 basic medicine, Male, Multivariate analysis, Radiography, 2745 Rheumatology, Severity of Illness Index, Cohort Studies, 0302 clinical medicine, Epidemiology, Axis, Cervical Vertebra/diagnostic imaging, Immunology and Allergy, Axis, Cervical Vertebra, ddc:616, Lumbar Vertebrae, Confounding, tnf, 10051 Rheumatology Clinic and Institute of Physical Medicine, Middle Aged, Treatment Outcome, Spine/diagnostic imaging/pathology, Cohort, 2723 Immunology and Allergy, Disease Progression, 10046 Balgrist University Hospital, Swiss Spinal Cord Injury Center, epidemiology, Female, Switzerland, Cohort study, Adult, medicine.medical_specialty, Lumbar Vertebrae/diagnostic imaging, Immunology, 610 Medicine & health, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, Rheumatology, 1300 General Biochemistry, Genetics and Molecular Biology, anti, Internal medicine, Severity of illness, ankylosing spondylitis, medicine, Humans, Spondylitis, Ankylosing, Axis, Cervical Vertebra/pathology, Follow-Up Studies, Lumbar Vertebrae/pathology, Multivariate Analysis, Spine/diagnostic imaging, Spine/pathology, Spondylitis, Ankylosing/diagnostic imaging, Spondylitis, Ankylosing/drug therapy, Spondylitis, Ankylosing/pathology, Tumor Necrosis Factor-alpha/antagonists & inhibitors, anti-tnf, 030203 arthritis & rheumatology, Ankylosing spondylitis, 2403 Immunology, Tumor Necrosis Factor-alpha, business.industry, medicine.disease, Spine, Axis, Cervical Vertebra/diagnostic imaging/pathology, Surgery, respiratory tract diseases, Spondylitis, Ankylosing/diagnostic imaging/drug therapy/pathology, 030104 developmental biology, Lumbar Vertebrae/diagnostic imaging/pathology, business

وصف الملف: application/pdf; annrheumdis-2017-211544.full.pdf - application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf092bb5e5c11fd580cecb5d08f6e4a8
https://hdl.handle.net/1887/76082

المؤلفون: Boonen, Annelies, Boone, Caroline, Albert, Adelin, Mielants, Herman

المصدر: Contextual factors influence work outcomes in employed patients with ankylosing spondylitis starting etanercept: 2-year results from AS@Work. Rheumatology (Oxford, England), 57(5), 791-797., United Kingdom. (2018).

مصطلحات موضوعية: Absenteeism, Activities of Daily Living/psychology, Adult, Antirheumatic Agents/administration & dosage, Dose-Response Relationship, Drug, Employment/psychology, Etanercept/administration & dosage, Female, Follow-Up Studies, Humans, Male, Presenteeism, Quality of Life, Severity of Illness Index, Spondylitis, Ankylosing/drug therapy/psychology, Surveys and Questionnaires, Time Factors, Human health sciences :: Rheumatology, Sciences de la santé humaine :: Rhumatologie

URL الوصول: https://orbi.uliege.be/handle/2268/234368

المؤلفون: Ahmet Gül, Ahmet Mesut Onat, Ayten Yazici, Sait Burak Erer, Meryem Can, Veli Cobankara, Servet Akar, Salih Pay, Levent Kilic, Bunyamin Kisacik, H. Direskeneli, Sedat Yilmaz, Fahrettin Oksel, Ayse Balkarli, Gökhan Keser, Ali Berkant Avci, Mehmet Sayarlioglu, Ihsan Ertenli, Ender Terzioglu, Ömer Nuri Pamuk, Ediz Dalkilic, Yavuz Pehlivan, Ayse Cefle, Yesim Ozguler, Süleyman Özbek, Gozde Yildirim Cetin, Gulen Hatemi

المساهمون: Ondokuz Mayıs Üniversitesi, Çukurova Üniversitesi, Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Romatoloji Bilim Dalı., Pehlivan, Yavuz, Dalkılıç, Ediz, AAG-8227-2021

مصطلحات موضوعية: rheumatoid arthritis, Male, demography, age distribution, TUBERCULOSIS REACTIVATION, Tnf, ISONIAZID, tumor necrosis factor alpha inhibitor, Turkey (republic), Arthritis, Rheumatoid, 0302 clinical medicine, rituximab, adalimumab, middle aged, Prevalence, Immunology and Allergy, TUMOR NECROSIS FACTOR-A INHIBITORS, 030212 general & internal medicine, risk, psoriatic arthritis, Latent tuberculosis, adult, disease course, pathogenesis, clinical trial, cohort analysis, female, Tuberculosis reactivation isoniazid, priority journal, risk factor, tuberculosis, Rheumatoid arthritis, Antirheumatic Agents, Tumor Necrosis Factor, Skin Tests, Interferon Gamma Release Assay, Cohort, Chemoprophylaxis, biological product, Tumor necrosis factor-A inhibitors, medicine.drug, medicine.medical_specialty, isoniazid, Tuberculosis, tumor necrosis factor, sex difference, Immunology, skin test, Infections, Article, 03 medical and health sciences, Rheumatology, Latent Tuberculosis, Rheumatoid-arthritis, Internal medicine, ankylosing spondylitis, medicine, Humans, controlled study, Spondylitis, Ankylosing, human, infection risk, extrapulmonary tuberculosis, antagonists and inhibitors, 030203 arthritis & rheumatology, Ankylosing spondylitis, Biological Products, business.industry, Tumor Necrosis Factor-alpha, prediction, Adult, Antirheumatic Agents/*adverse effects/therapeutic use, Arthritis, Rheumatoid/drug therapy, Biological Products/*adverse effects/therapeutic use, Female, Latent Tuberculosis/*diagnosis, Middle Aged, Risk, Spondylitis, Ankylosing/drug therapy, Tuberculosis/*epidemiology/*etiology, Tumor Necrosis Factor-alpha/*antagonists & inhibitors, Term, medicine.disease, major clinical study, mortality, Infliximab, Surgery, clinical feature, multicenter study, Factor antagonists, antirheumatic agent, Therapy, business, infliximab, etanercept, Behcet disease

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87c0a286059f87580c2279057eb112a6
https://doi.org/10.3899/jrheum.150177

المؤلفون: Susanne Qvitzau, Andrew J. K. Östör, Alan Reynolds, Rose-Marie Lindkvist, Mats Ekelund, Per Larsson, Robert J. Moots, Pentti Järvinen, Anne G. R. Loft, Danuta Kielar

المصدر: Moots, R J, Ostor, A J K, Loft, A G R, Järvinen, P, Larsson, P, Ekelund, M, Reynolds, A, Kielar, D, Lindkvist, R-M & Qvitzau, S 2012, ' Reduction of direct and indirect costs in patients with AS receiving etanercept : results from an open-label 36-week extension of the ASCEND study in four European countries ', Rheumatology, vol. 51, no. 2, pp. 393-6 . https://doi.org/10.1093/rheumatology/ker404

مصطلحات موضوعية: Adult, Employment, Male, medicine.medical_specialty, Sick Leave/statistics & numerical data, Efficiency, Immunoglobulin G/administration & dosage, Receptors, Tumor Necrosis Factor, Etanercept, Young Adult, Indirect costs, Antirheumatic Agents/administration & dosage, Rheumatology, Quality of life, Spondylitis, Ankylosing/drug therapy, Health care, medicine, Humans, Spondylitis, Ankylosing, Pharmacology (medical), In patient, Receptors, Tumor Necrosis Factor/administration & dosage, health care economics and organizations, Aged, Work productivity, business.industry, Health Care Costs, Middle Aged, humanities, Treatment Outcome, Antirheumatic Agents, Immunoglobulin G, Sick leave, Quality of Life, Physical therapy, Female, Sick Leave, Open label, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1bf42659488942e087c8e5568d93c17
https://doi.org/10.1093/rheumatology/ker404

المؤلفون: Mikkel Østergaard, Anne-Dorthe Piil, Jesper Nørregaard, Robert G. W. Lambert, Oliver Hendricks, A G Jurik, Gorm Thamsborg, Joachim Sieper, Karsten Asmussen, Jakob M Møller, Denis Poddubnyy, Inge Juul Sørensen, Lone Balding, Jens S. Hindrup, Susanne Juhl Pedersen, Anne-Gitte Loft

المصدر: Pedersen, S J, Poddubnyy, D, Sørensen, I J, Loft, A-G, Hindrup, J S, Thamsborg, G, Asmussen, K, Hendricks, O, Nørregaard, J, Piil, A-D, Møller, J M, Jurik, A-G, Balding, L, Lambert, R G, Sieper, J & Østergaard, M 2016, ' Course of Magnetic Resonance Imaging–Detected Inflammation and Structural Lesions in the Sacroiliac Joints of Patients in the Randomized, Double-Blind, Placebo-Controlled Danish Multi center Study of Adalimumab in Spondyloarthritis, as Assessed by the Berlin and Spondyloarthritis Research Consortium of Canada Methods ', Arthritis & Rheumatology, vol. 68, no. 2, pp. 418-429 . https://doi.org/10.1002/art.39434
Pedersen, S J, Poddubnyy, D, Sørensen, I J, Loft, A-G, Hindrup, J S, Thamsborg, G, Asmussen, K, Hendricks, O, Nørregaard, J, Piil, A-D, Møller, J M, Jurik, A-G, Balding, L, Lambert, R G, Sieper, J & Østergaard, M 2016, ' Course of Magnetic Resonance Imaging-Detected Inflammation and Structural Lesions in the Sacroiliac Joints of Patients in the Randomized, Double-Blind, Placebo-Controlled Danish Multicenter Study of Adalimumab in Spondyloarthritis, as Assessed by the Berlin and Spondyloarthritis Research Consortium of Canada Methods ', Arthritis & Rheumatology, vol. 68, no. 2, pp. 418-29 . https://doi.org/10.1002/art.39434

مصطلحات موضوعية: 0301 basic medicine, Male, Denmark, Antirheumatic Agents/therapeutic use, Gastroenterology, law.invention, 0302 clinical medicine, Randomized controlled trial, law, Spondylitis, Ankylosing/drug therapy, Sacroiliac Joint/pathology, Immunology and Allergy, skin and connective tissue diseases, Sacroiliac joint, medicine.diagnostic_test, Spondylarthropathies/drug therapy, Middle Aged, Magnetic Resonance Imaging, humanities, medicine.anatomical_structure, Treatment Outcome, Antirheumatic Agents, Female, medicine.symptom, medicine.drug, musculoskeletal diseases, Adult, medicine.medical_specialty, Immunology, Inflammation, Placebo, Lesion, 03 medical and health sciences, Rheumatology, Double-Blind Method, Adalimumab/therapeutic use, Internal medicine, medicine, Adalimumab, Humans, Spondylitis, Ankylosing, Spondylitis, 030203 arthritis & rheumatology, business.industry, Magnetic resonance imaging, Sacroiliac Joint, medicine.disease, Surgery, 030104 developmental biology, Spondylarthropathies, business, Inflammation/pathology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c0c022e7ac9d3b0b2e353477c4a3814
https://pubmed.ncbi.nlm.nih.gov/26414004

المؤلفون: Victoria Fana, L. Ejstrup, Natalia Manilo, Bente Glintborg, Ulrik Tarp, Merete Lund Hetland, Mikkel Østergaard, Annette Schlemmer, Henrik Nordin, Niels Steen Krogh, Hanne Merete Lindegaard, Dorte Vendelbo Jensen, Anne Gitte Loft, Peter Mosborg Petersen, Claus Rasmussen, Annette Hansen

المصدر: Glintborg, B, Østergaard, M, Krogh, N S, Tarp, U, Manilo, N, Loft, A G R, Hansen, A, Schlemmer, A, Fana, V, Lindegaard, H M, Nordin, H, Rasmussen, C, Ejstrup, L, Jensen, D V, Petersen, P M & Hetland, M L 2013, ' Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy : results from the Danish nationwide DANBIO registry ', Annals of the Rheumatic Diseases, vol. 72, no. 7, pp. 1149-55 . https://doi.org/10.1136/annrheumdis-2012-201933
Glintborg, B, Ostergaard, M, Krogh, N S, Tarp, U, Manilo, N, Loft, A G R, Hansen, A, Schlemmer, A, Fana, V, Lindegaard, H M, Nordin, H, Rasmussen, C, Ejstrup, L, Jensen, D V, Petersen, P M & Hetland, M L 2013, ' Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy : results from the Danish nationwide DANBIO registry ', Annals of the Rheumatic Diseases, pp. 1149-1155 . https://doi.org/10.1136/annrheumdis-2012-201933
Glintborg, B, Østergaard, M, Krogh, N S, Tarp, U, Manilo, N, Loft, A G R, Hansen, A, Schlemmer, A, Fana, V, Lindegaard, H M, Nordin, H, Rasmussen, C, Ejstrup, L, Jensen, D V, Petersen, P M & Hetland, M L 2013, ' Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy : Results from the Danish nationwide DANBIO registry ', Annals of the Rheumatic Diseases, vol. 72, no. 7, pp. 1149-1155 . https://doi.org/10.1136/annrheumdis-2012-201933

مصطلحات موضوعية: Male, Receptors, Tumor Necrosis Factor/therapeutic use, Denmark, Antirheumatic Agents/therapeutic use, Receptors, Tumor Necrosis Factor, Etanercept, Spondylitis, Ankylosing/drug therapy, Immunology and Allergy, Registries, BASDAI, Pain Measurement, Drug Substitution, Antibodies, Monoclonal, Middle Aged, Treatment Outcome, Antibodies, Monoclonal, Humanized/therapeutic use, Rheumatoid arthritis, Antirheumatic Agents, Medication Adherence/statistics & numerical data, Female, medicine.drug, Adult, medicine.medical_specialty, Immunology, Antibodies, Monoclonal/therapeutic use, Immunoglobulin G/therapeutic use, Antibodies, Monoclonal, Humanized, General Biochemistry, Genetics and Molecular Biology, Medication Adherence, Rheumatology, Internal medicine, medicine, Adalimumab, Humans, Spondylitis, Ankylosing, Spondylitis, Ankylosing spondylitis, Tumor Necrosis Factor-alpha/antagonists & inhibitors, business.industry, Tumor Necrosis Factor-alpha, medicine.disease, Infliximab, Drug Substitution/statistics & numerical data, Immunoglobulin G, Physical therapy, business, BASFI

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::655dfdcf0410711c44a55095e3a55fe7
https://vbn.aau.dk/da/publications/322faf95-329a-4634-b4f1-d9e2db3f9739